United States Assisted Reproductive Technology Market Size, Share & Trends 2024-2032

Written by kishanroy » Updated on: November 19th, 2024

IMARC Group has published a market research report titled "United States Assisted Reproductive Technology Market Report by Product (Instrument, Accessory and Disposable, Reagents and Media), Type (In-Vitro Fertilization (IVF), Artificial Insemination), End Use (Fertility Clinics and Other Facilities, Hospitals and Others), and Region 2024-2032", United States assisted reproductive technology market size is projected to exhibit a growth rate (CAGR) of 7.10% during 2024-2032.

The increasing prevalence of infertility issues among couples and the rising awareness and acceptance of ART procedures are propelling the United States assisted reproductive technology (ART) market. Additionally, growing lifestyle-related issues such as delayed family planning due to professional commitments, lifestyle-related health issues, and the escalating incidence of infertility-related medical conditions are fueling the demand for assisted reproductive technology (ART). Besides this, advancements in reproductive technologies, including in vitro fertilization and intracytoplasmic sperm injection, have improved success rates, making these options more appealing to individuals and couples seeking fertility assistance, which is bolstering the market. Moreover, the legal and regulatory framework in the United States, which is supportive of ART procedures, and the coverage of these treatments by certain insurance policies, further bolster the growth of the market.

Grab a sample PDF of this report: https://www.imarcgroup.com/united-states-assisted-reproductive-technology-market/requestsample

United States Assisted Reproductive Technology Market Trends and Drivers:

Emerging trends in the United States assisted reproductive technology (ART) market include the integration of advanced technologies like machine learning, artificial intelligence, etc., in the screening and analysis of embryos, which can significantly enhance the precision and success rates of ART procedures. In addition to this, there is a growing emphasis on personalized medicine approaches, tailoring treatments to the specific genetic and health profiles of individuals to improve outcomes, which is creating a positive outlook for the market. Furthermore, the market is also witnessing an increase in egg-freezing services as more women choose to preserve their fertility for future family planning, which is anticipated to drive the United States assisted reproductive technology (ART) market in the forecasted period.

Report Segmentation:

The report has segmented the market into the following categories:

Product Insights:

Instrument

Sperm Separation System

Cryosystem

Incubator

Imaging System

Ovum Aspiration Pump

Cabinet

Micromanipulator

Laser Systems

Others

Accessory and Disposable

Reagents and Media

Cryopreservation Media

Semen Processing Media

Ovum Processing Media

Embryo Culture Media

Type Insights:

In-Vitro Fertilization (IVF)

Fresh Donor

Frozen Donor

Fresh Non-Donor

Frozen Non-Donor

Artificial Insemination

Intrauterine Insemination

Intracervical Insemination

Intravaginal Insemination

Intratubal Insemination

End Use Insights:

Fertility Clinics and Other Facilities

Hospitals and Others

Regional Insights:

Northeast

Midwest

South

West

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

Disclaimer:

We do not claim ownership of any content, links or images featured on this post unless explicitly stated. If you believe any content or images infringes on your copyright, please contact us immediately for removal ([email protected]). Please note that content published under our account may be sponsored or contributed by guest authors. We assume no responsibility for the accuracy or originality of such content. We hold no responsibilty of content and images published as ours is a publishers platform. Mail us for any query and we will remove that content/image immediately.